fluphenazine enanthate has been researched along with Dyskinesia, Drug-Induced in 5 studies
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The fluphenazine treatment produced VCMs in the majority of the treated rats (87% after 24 weeks)." | 1.34 | Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats. ( Braga, AL; Calixto, JB; Fachinetto, R; Ferreira, J; Paixão, MW; Pereira, RP; Puntel, RL; Rocha, JB; Villarinho, JG; Wagner, C, 2007) |
| "Haloperidol was given first in doses of 1." | 1.27 | Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review. ( Domino, EF, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fachinetto, R | 1 |
| Villarinho, JG | 1 |
| Wagner, C | 1 |
| Pereira, RP | 1 |
| Puntel, RL | 1 |
| Paixão, MW | 1 |
| Braga, AL | 1 |
| Calixto, JB | 1 |
| Rocha, JB | 1 |
| Ferreira, J | 1 |
| Glazer, WM | 1 |
| Domino, EF | 3 |
| Kovacic, B | 2 |
1 review available for fluphenazine enanthate and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
1 trial available for fluphenazine enanthate and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Fe | 1984 |
4 other studies available for fluphenazine enanthate and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Benzene Derivatives; Disease Models, | 2007 |
Monkey models of tardive dyskinesia.
Topics: Animals; Benztropine; Biperiden; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fl | 1983 |
A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Stre | 1982 |
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Thera | 1985 |